EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for CELC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 -1.439
March 31, 2026 -0.9702
December 31, 2025 -0.9702
September 30, 2025 -0.9204
June 30, 2025 -1.037
March 31, 2025 -0.8593
December 31, 2024 -0.8549
September 30, 2024 -0.6962
June 30, 2024 -0.617
March 31, 2024 -0.643
December 31, 2023 -0.6522
September 30, 2023 -0.8321
June 30, 2023 -0.6644
March 31, 2023 -0.5506
December 31, 2022 -0.6864
September 30, 2022 -0.7292
June 30, 2022 -0.6671
March 31, 2022 -0.5319
December 31, 2021 -0.4529
September 30, 2021 -0.4051
Date Value
June 30, 2021 -1.113
March 31, 2021 -0.2521
December 31, 2020 -0.2482
September 30, 2020 -0.2408
June 30, 2020 -0.2146
March 31, 2020 -0.2191
December 31, 2019 -0.1765
September 30, 2019 -0.1938
June 30, 2019 -0.1684
March 31, 2019 -0.181
December 31, 2018 -0.1796
September 30, 2018 -0.1847
June 30, 2018 -0.18
March 31, 2018 -0.1949
December 31, 2017 -0.17
September 30, 2017 -0.26
June 30, 2017 -0.28
March 31, 2017 -0.0038
June 30, 2016 -0.0843
March 31, 2016 -0.003

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Cogent Biosciences, Inc. -0.5636
Replimune Group, Inc. -0.7202
Erasca, Inc. -0.1416
Apogee Therapeutics, Inc. -1.138
Arrowhead Pharmaceuticals, Inc. -1.355

EPS Diluted (Quarterly) Related Metrics